Sign inGet started

Warren Eric

Insider CIK 1916048 · ESPR Chief Commercial Officer · MLYS Chief Commercial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
MLYS Mineralys Therapeutics, In M Exercise deriv2026-09-212026-09-227,438— $0230,563SEC↗
MLYS Mineralys Therapeutics, In M Exercise2026-09-212026-09-227,438$13.24 $98.5K45,838SEC↗
MLYS Mineralys Therapeutics, In S Sale2026-09-212026-09-227,438$28.12 $209.2K38,400SEC↗
MLYS Mineralys Therapeutics, In M Exercise deriv2026-09-212026-09-227,438— $0230,563SEC↗
MLYS Mineralys Therapeutics, In S Sale2026-09-212026-09-227,438$28.12 $209.1K38,400SEC↗
MLYS Mineralys Therapeutics, In M Exercise2026-09-212026-09-227,438$13.24 $98.5K45,838SEC↗
MLYS Mineralys Therapeutics, In M Exercise deriv2026-08-212026-08-257,437— $0238,001SEC↗
MLYS Mineralys Therapeutics, In S Sale2026-08-212026-08-257,437$25.98 $193.2K38,400SEC↗
MLYS Mineralys Therapeutics, In M Exercise2026-08-212026-08-257,437$13.24 $98.5K45,837SEC↗
MLYS Mineralys Therapeutics, In M Exercise deriv2026-08-212026-08-257,437— $0238,001SEC↗
MLYS Mineralys Therapeutics, In S Sale2026-08-212026-08-257,437$25.98 $193.2K38,400SEC↗
MLYS Mineralys Therapeutics, In M Exercise2026-08-212026-08-257,437$13.24 $98.5K45,837SEC↗
MLYS Mineralys Therapeutics, In M Exercise deriv2026-07-212026-07-237,438— $0245,438SEC↗
MLYS Mineralys Therapeutics, In M Exercise2026-07-212026-07-237,438$13.24 $98.5K45,838SEC↗
MLYS Mineralys Therapeutics, In S Sale2026-07-212026-07-237,438$26.87 $199.9K38,400SEC↗
MLYS Mineralys Therapeutics, In M Exercise deriv2026-06-262026-06-30104,124— $0252,876SEC↗
MLYS Mineralys Therapeutics, In S Sale2026-06-262026-06-30104,124$25.90 $2.70M38,400SEC↗
MLYS Mineralys Therapeutics, In M Exercise2026-06-262026-06-30104,124$13.24 $1.38M142,524SEC↗
ESPR Esperion Therapeutics, Inc S Sale2025-04-172025-04-21108$0.98 $106370,218SEC↗
ESPR Esperion Therapeutics, Inc S Sale2025-03-182025-03-192,433$1.49 $3.6K370,326SEC↗
ESPR Esperion Therapeutics, Inc A Award deriv2025-03-142025-03-17191,000— $0191,000SEC↗
ESPR Esperion Therapeutics, Inc A Award2025-03-142025-03-17213,000— $0372,759SEC↗
ESPR Esperion Therapeutics, Inc S Sale2025-02-192025-02-20239$1.87 $447159,759SEC↗
ESPR Esperion Therapeutics, Inc S Sale2025-01-172025-01-21123$2.26 $278159,998SEC↗
ESPR Esperion Therapeutics, Inc S Sale2024-12-172024-12-182,234$2.43 $5.4K160,121SEC↗
ESPR Esperion Therapeutics, Inc S Sale2024-11-192024-11-20197$2.17 $427162,355SEC↗
ESPR Esperion Therapeutics, Inc S Sale2024-10-172024-10-18107$2.12 $227162,552SEC↗
ESPR Esperion Therapeutics, Inc S Sale2024-09-172024-09-182,608$1.78 $4.6K162,659SEC↗
ESPR Esperion Therapeutics, Inc S Sale2024-08-192024-08-20211$1.95 $411165,267SEC↗
ESPR Esperion Therapeutics, Inc S Sale2024-07-172024-07-19108$2.59 $280165,478SEC↗
ESPR Esperion Therapeutics, Inc S Sale2024-06-182024-06-202,540$2.86 $7.3K165,586SEC↗
ESPR Esperion Therapeutics, Inc S Sale2024-05-172024-05-20192$2.48 $476168,126SEC↗
ESPR Esperion Therapeutics, Inc A Award deriv2024-03-142024-03-15150,000— $0150,000SEC↗
ESPR Esperion Therapeutics, Inc A Award2024-03-142024-03-15100,000— $0168,318SEC↗
ESPR Esperion Therapeutics, Inc S Sale2023-09-202023-09-21742$1.25 $92868,318SEC↗
ESPR Esperion Therapeutics, Inc S Sale2023-08-182023-08-21243$1.41 $34369,060SEC↗
ESPR Esperion Therapeutics, Inc S Sale2023-07-192023-07-20106$1.59 $16969,303SEC↗
ESPR Esperion Therapeutics, Inc S Sale2023-06-212023-06-22603$1.48 $89269,409SEC↗
ESPR Esperion Therapeutics, Inc S Sale2023-05-172023-05-18219$1.62 $35570,012SEC↗
ESPR Esperion Therapeutics, Inc S Sale2023-04-192023-04-20115$1.28 $14770,231SEC↗
ESPR Esperion Therapeutics, Inc S Sale2023-03-172023-03-20526$1.78 $93670,346SEC↗
ESPR Esperion Therapeutics, Inc A Award deriv2023-03-142023-03-1594,500— $094,500SEC↗
ESPR Esperion Therapeutics, Inc A Award2023-03-142023-03-1522,300— $070,872SEC↗
ESPR Esperion Therapeutics, Inc S Sale2023-03-072023-03-085,090$5.06 $25.8K48,572SEC↗
ESPR Esperion Therapeutics, Inc S Sale2022-10-182022-10-19107$7.69 $82353,662SEC↗
ESPR Esperion Therapeutics, Inc S Sale2022-09-192022-09-20255$6.92 $1.8K53,769SEC↗
ESPR Esperion Therapeutics, Inc P Buy2022-08-312022-08-311,000$7.46 $7.5K54,024SEC↗
ESPR Esperion Therapeutics, Inc S Sale2022-08-172022-08-18199$6.82 $1.4K53,024SEC↗
ESPR Esperion Therapeutics, Inc S Sale2022-07-192022-07-20431$6.58 $2.8K53,223SEC↗
ESPR Esperion Therapeutics, Inc S Sale2022-06-172022-06-21256$4.90 $1.3K53,654SEC↗
ESPR Esperion Therapeutics, Inc A Award deriv2022-06-072022-06-0952,000— $052,000SEC↗
ESPR Esperion Therapeutics, Inc S Sale2022-05-172022-05-18196$5.98 $1.2K53,910SEC↗
ESPR Esperion Therapeutics, Inc A Award2022-03-142022-03-1613,000— $054,106SEC↗